Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
about
Biomarkers for the early diagnosis of hepatocellular carcinomaDeregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis.Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma.Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care.STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
P2860
Q26784418-04D29AC4-5283-4C9B-BC67-89B87B4DA505Q33815856-0CC62394-81B1-42D6-806F-2C63DA5A6E4EQ36232174-7A767AC4-D3CA-4FC0-80D4-38C2C528436EQ38859488-19DDBBAD-FDD7-4DE6-B137-AEEF97F01DF7Q40193396-0539D562-9C12-4B41-9B78-D82F155E4CCFQ41428743-79D7AAD3-FCA2-465A-A984-B807373D4979Q41928061-B2E6CBCF-8380-4B67-8871-A8368ED53B22Q52694945-B970F383-BD80-43A0-A8C8-63203E336A27
P2860
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
@ast
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
@en
type
label
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
@ast
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
@en
prefLabel
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
@ast
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
@en
P2093
Meng-Chao Wu
Wan Yee Lau
Xu-Ying Wan
Zhang-Jun Cheng
P2860
P304
P356
10.18632/ONCOTARGET.3314
P407
P577
2015-04-01T00:00:00Z